CD276 CAR-T cells 비교 | 바이오정보모아

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

Overview Toxicology Clinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목	CGTStandard DatabasestalePhase 2 CD276 CAR-T cells (CD276 CAR-T cells) Shenzhen University General Hospit…·Advanced Pancreatic Carcinoma 1 trials

Overview Program	CD276 CAR-T cells
Overview Company	Shenzhen University General Hospital
Overview Modality	CGT
Overview Target	Advanced Pancreatic Carcinoma
Overview Indication	Advanced Pancreatic Carcinoma
Overview Phase	PHASE_2
Overview Status	ACTIVE
Overview Content status	Standard Database
Overview Data Confidence	Data Confidence · Medium
Overview Development Signal	Development Signal · Emerging
Overview Approval status	Investigational

Toxicology Major finding	pneumonitis) was reported in one patient at the 5 × 108 cell dose level
Toxicology CRS	Reported

Clinical Safety signal	pneumonitis) was reported in one patient at the 5 × 108 cell dose level
Clinical Program phase	PHASE_2

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

프로그램 선택

Overview Toxicology Clinical

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목	CGTStandard DatabasestalePhase 2 CD276 CAR-T cells (CD276 CAR-T cells) Shenzhen University General Hospit…·Advanced Pancreatic Carcinoma 1 trials

Overview Program	CD276 CAR-T cells
Overview Company	Shenzhen University General Hospital
Overview Modality	CGT
Overview Target	Advanced Pancreatic Carcinoma
Overview Indication	Advanced Pancreatic Carcinoma
Overview Phase	PHASE_2
Overview Status	ACTIVE
Overview Content status	Standard Database
Overview Data Confidence	Data Confidence · Medium
Overview Development Signal	Development Signal · Emerging
Overview Approval status	Investigational

Toxicology Major finding	pneumonitis) was reported in one patient at the 5 × 108 cell dose level
Toxicology CRS	Reported

Clinical Safety signal	pneumonitis) was reported in one patient at the 5 × 108 cell dose level
Clinical Program phase	PHASE_2